メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Erythropoietin Drugs Market Size Growth Rate by Type (2020-2025)
1.3.2 Epoetin-alfa
1.3.3 Darbepoetin-alfa
1.3.4 Epoetin-beta
1.3.5 Others
1.4 Market Segment by Application
1.4.1 Global Erythropoietin Drugs Market Share by Application (2020-2025)
1.4.2 Anemia
1.4.3 Kidney Disorders
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erythropoietin Drugs Market Size
2.1.1 Global Erythropoietin Drugs Revenue 2015-2025
2.1.2 Global Erythropoietin Drugs Sales 2015-2025
2.2 Erythropoietin Drugs Growth Rate by Regions
2.2.1 Global Erythropoietin Drugs Sales by Regions 2015-2019
2.2.2 Global Erythropoietin Drugs Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Erythropoietin Drugs Sales by Manufacturers
3.1.1 Erythropoietin Drugs Sales by Manufacturers 2015-2019
3.1.2 Erythropoietin Drugs Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Erythropoietin Drugs Revenue by Manufacturers (2015-2019)
3.2.2 Erythropoietin Drugs Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Erythropoietin Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Erythropoietin Drugs Price by Manufacturers
3.4 Key Manufacturers Erythropoietin Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Erythropoietin Drugs Market
3.6 Key Manufacturers Erythropoietin Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Epoetin-alfa Sales and Revenue (2015-2019)
4.1.2 Darbepoetin-alfa Sales and Revenue (2015-2019)
4.1.3 Epoetin-beta Sales and Revenue (2015-2019)
4.1.4 Others Sales and Revenue (2015-2019)
4.2 Global Erythropoietin Drugs Sales Market Share by Type
4.3 Global Erythropoietin Drugs Revenue Market Share by Type
4.4 Erythropoietin Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Erythropoietin Drugs Sales by Application
6 United States
6.1 United States Erythropoietin Drugs Breakdown Data by Company
6.2 United States Erythropoietin Drugs Breakdown Data by Type
6.3 United States Erythropoietin Drugs Breakdown Data by Application
7 European Union
7.1 European Union Erythropoietin Drugs Breakdown Data by Company
7.2 European Union Erythropoietin Drugs Breakdown Data by Type
7.3 European Union Erythropoietin Drugs Breakdown Data by Application
8 China
8.1 China Erythropoietin Drugs Breakdown Data by Company
8.2 China Erythropoietin Drugs Breakdown Data by Type
8.3 China Erythropoietin Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Erythropoietin Drugs Breakdown Data by Company
9.2 Rest of World Erythropoietin Drugs Breakdown Data by Type
9.3 Rest of World Erythropoietin Drugs Breakdown Data by Application
9.4 Rest of World Erythropoietin Drugs Breakdown Data by Countries
9.4.1 Rest of World Erythropoietin Drugs Sales by Countries
9.4.2 Rest of World Erythropoietin Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.1.4 Erythropoietin Drugs Product Introduction
10.1.5 Amgen Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.2.4 Erythropoietin Drugs Product Introduction
10.2.5 Johnson & Johnson Recent Development
10.3 Roche
10.3.1 Roche Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.3.4 Erythropoietin Drugs Product Introduction
10.3.5 Roche Recent Development
10.4 Galenica
10.4.1 Galenica Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.4.4 Erythropoietin Drugs Product Introduction
10.4.5 Galenica Recent Development
10.5 Emcure
10.5.1 Emcure Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.5.4 Erythropoietin Drugs Product Introduction
10.5.5 Emcure Recent Development
10.6 Kyowa Hakko Kirin
10.6.1 Kyowa Hakko Kirin Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.6.4 Erythropoietin Drugs Product Introduction
10.6.5 Kyowa Hakko Kirin Recent Development
10.7 3SBio
10.7.1 3SBio Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.7.4 Erythropoietin Drugs Product Introduction
10.7.5 3SBio Recent Development
10.8 Biocon
10.8.1 Biocon Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.8.4 Erythropoietin Drugs Product Introduction
10.8.5 Biocon Recent Development
10.9 LG Life Sciences
10.9.1 LG Life Sciences Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Erythropoietin Drugs
10.9.4 Erythropoietin Drugs Product Introduction
10.9.5 LG Life Sciences Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Erythropoietin Drugs Sales Channels
11.2.2 Erythropoietin Drugs Distributors
11.3 Erythropoietin Drugs Customers
12 Market Forecast
12.1 Global Erythropoietin Drugs Sales and Revenue Forecast 2020-2025
12.2 Global Erythropoietin Drugs Sales Forecast by Type
12.3 Global Erythropoietin Drugs Sales Forecast by Application
12.4 Erythropoietin Drugs Forecast by Regions
12.4.1 Global Erythropoietin Drugs Sales Forecast by Regions 2020-2025
12.4.2 Global Erythropoietin Drugs Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
